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Staphylococcus epidermidis is an abundant member of the microbiota of the human skin and wet mucosa, which is commonly
associated with sight-threatening infections in eyes with predisposing factors. Ocular S. epidermidis has become notorious be-
cause of its capability to form biofilms on different ocular devices and due to the evolving rates of antimicrobial resistance. In
this study, the molecular epidemiology of 30 ocular methicillin-resistant S. epidermidis (MRSE) isolates was assessed using mul-
tilocus sequence typing (MLST). Antimicrobial resistance, accessory gene-regulator and staphylococcal cassette chromosome
mec (SCCmec) types, biofilm formation, and the occurrence of biofilm-associated genes were correlated withMLST clonal com-
plexes. Sequence types (STs) frequently found in the hospital setting were rarely found in our collection. Overall, 12 different STs
were detected with a predominance of ST59 (30%), ST5 and ST6 (13.3% each). Most of the isolates (93.3%) belonged to the clonal
complex 2 (CC2) and groupedmainly within subcluster CC2-II (92.9%). Isolates grouped within this subcluster were frequently
biofilm producers (92.3%) with a higher occurrence of the aap (84.5%) and bhp (46.1%) genes compared to icaA (19.2%).
SCCmec type IV (53.8%) was predominant within CC2-II strains, while 38.4%were nontypeable. In addition, CC2-II strains
were frequently multidrug resistant (80.7%) and demonstrated to be particularly resistant to ciprofloxacin (80.8%), ofloxacin
(77%), azithromycin (61.5%), and gentamicin (57.7%). Our findings demonstrate the predominance of a particular MRSE clus-
ter causing ocular infections, which was associated with high rates of antimicrobial resistance and particularly the carriage of
biofilm-related genes coding for proteinaceous factors implicated in biofilm accumulation.
Staphylococcus epidermidis is the main colonizer of the humanskin and wet mucosa, where it maintains a benign relationship
with the host. Although found as a common constituent of the
ocular surfacemicrobiota (1), S. epidermidis is the leading cause of
bacterial endophthalmitis following trauma and intraocular pro-
cedures (2, 3) and has been frequently associated with infectious
keratitis worldwide in patients with predisposing risk factors, in-
cluding contact lens wear, trauma, surgery, and ocular surface
inflammatory diseases (4, 5). The success of S. epidermidis as a
pathogen is particularly attributed to its capability to form ag-
glomerations of cells embedded in and protected by an extracel-
lularmatrix composed of polysaccharides and/or proteins, known
as biofilm, which confers resistance to antibiotic action and host
immune defenses (6). Biofilm formation is a process that begins
first with adhesion of bacterial cells to abiotic or protein-coated
biotic surfaces mediated by numerous surface proteins, followed
by an accumulation process mediated by a polysaccharide inter-
cellular adhesin (PIA) encoded by the icaADBC locus and also by
proteinaceous factors such as Aap (accumulation-associated pro-
tein) (7). The biofilm-associated homologue protein, Bhp, is also
possibly involved in biofilm accumulation (8). In addition, the
association between biofilm formation capability and the emerg-
ing resistance to antibiotics used routinely for prophylaxis and
treatment of ocular infections (9, 10) increases the success of S.
epidermidis as an ocular pathogen. Although beta-lactams are not
frequently used in ophthalmology, methicillin resistance is a key
mechanism of resistance in staphylococci and is significantly as-
sociated with higher resistance rates to other non-beta-lactam
agents, contributing to the spread and persistence of multidrug-
resistant strains in several settings. The rates of methicillin resis-
tance among ocular staphylococci isolates are currently on the rise
(11–13). Resistance tomethicillin in both S. aureus and coagulase-
negative staphylococci (CoNS) is conferred by an altered penicil-
lin-binding protein (PBP2a) with reduced affinity for beta-lactam
antibiotics (14). PBP2a is encoded by the mecA gene, which is
carried in the mobile genetic element called the staphylococcal
cassette chromosome mec (SCCmec) (15). In addition, SCCmec
also carries a set of recombinase genes (ccr), which are implicated
in the recombination events of SCCmec with the staphylococcal
chromosome (15). Currently, SCCmec types are usually deter-
mined by a combination of the ccr gene complex type and the class
of mec gene complex (16). To date, 11 SCCmec types have been
identified among methicillin-resistant S. aureus isolates (http:
//www.sccmec.org/Pages/SCC_TypesEN.html). In CoNS, includ-
ing S. epidermidis, the variability of SCCmec regions is greater than
in S. aureus, with a number of isolates carrying multiple ccr types
or ccr/mec complex combinations not yet described in S. aureus.
As a result, methicillin-resistant S. epidermidis (MRSE) carrying
nontypeable SCCmec elements by current protocols are frequently
found (17).
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Several molecular typing methods have been used to study the
molecular epidemiology of S. epidermidis (including methicillin-
resistant strains), but most of them do not allow the inference of
epidemiological relationships in long-term investigations and
the population structure (18). Pulsed-field gel electrophoresis
(PFGE) is the most discriminatory method for characterizing S.
epidermidis and has been widely used for studying the dissemina-
tion of MRSE clones in hospitals and community (19–22). How-
ever, its application has beenmore restricted to short-term epide-
miology for characterization of hospital outbreaks (18, 21).
Multilocus sequence typing (MLST) scheme is currently applied
for long-term evolutionary analysis and has provided additional
insights into the population structure of S. epidermidis isolates
from hospital and community settings (22, 23). However, despite
the importance of S. epidermidis as an ocular pathogen and its
emerging rates of resistance to antimicrobial agents, no informa-
tion on the molecular diversity of ocular isolates is available.
Therefore, this study was performed to assess the molecular epi-
demiology of MRSE isolates from keratitis and endophthalmitis
using the currently used MLST scheme. Molecular typing results
were correlated with antimicrobial resistance, accessory gene-reg-
ulator (agr) types and SCCmec types, and the occurrence of bio-
film-associated genes and in vitro biofilm formation capability.
MATERIALS AND METHODS
Bacterial isolates. A total of 30 consecutive, nonduplicate MRSE isolates
recovered fromkeratitis (n 27) and endophthalmitis (n 03) cases seen
at the Department of Ophthalmology, Federal University of Sao Paulo, in
2009 were included. Isolates stored at 80°C in tryptic soy broth (TSB)
with 15% glycerol were inoculated on 5% sheep blood agar before testing.
Species-level identification was accomplished by matrix-assisted laser de-
sorption ionization–time of flight (MALDI-TOF)mass spectrometrywith
a Microflex mass spectrometer (Bruker Daltonik, Bremen, Germany) us-
ing MALDI Biotyper 2.0 software as previously published (24).
Antimicrobial susceptibility testing. Antimicrobial susceptibility
testing was performed by broth microdilution methods according to the
Clinical and Laboratory Standards Institute (CLSI) (25). Quality control
was performed by testing S. aureus ATCC 29213, E. faecalis ATCC 29212,
and P. aeruginosa ATCC 27853. The interpretative criteria for each anti-
microbial agent tested were those published previously as CLSI document
M100-S13 (26).
In vitro polystyrene adherence. In vitro biofilm formation was deter-
mined by the modified microtiter-plate quantitative protocol as previ-
ously described (27). Staphylococcus epidermidis ATCC 12228 and ATCC
35984 were used as negative and positive controls, respectively. Absor-
bance was read at 570 nm using a Synergy HT Multi-Mode microplate
reader (BioTek Vermont, USA). Each sample and positive and negative
(only broth) controls were cultured in triplicate and in three independent
experiments. The results of all experiments were averaged.
DNA extraction. DNA extraction was performed using Chelex 100
molecular biology resin (Bio-Rad) as previously published with slight
modifications (28). Briefly, isolates from fresh cultures on 5% blood agar
were harvested and grown in 5ml of TSBovernight. An aliquot of 1mlwas
centrifuged for 5 min at 13,000 rpm and then washed twice using 1
phosphate-buffered saline. Pellets were resuspended in 300 l of 10%
Chelex 100 resin and incubated for 30 min at 95°C. After centrifugation
for 5 min at 13,000 rpm, a 1-l aliquot of the supernatant was collected,
diluted 1:10 and then used in the PCR amplification protocols.
SCCmec typing. The SCCmec types were determined by a combina-
tion of multiplex PCR designed to classify the mec complex and ccr com-
plex using a previously published protocol (16). For each multiplex PCR
assay, reference S. aureus strains for SCCmec types I (NCTC10442), II
(N315), III (85/2082), IV (CA05), and V (WIS) were included. SCCmec
was considered nontypeable ifmec and/or ccr complex gave no amplifica-
tion results or if the isolate carried more than one ccr ormec complex and
also if there was an mec/ccr complex combination not previously de-
scribed.
Detection of biofilm-related genes and agr typing. Amplification of
the icaAD (29), aap (30), and bhp genes and the insertion sequence IS256
(31)were carried out according to previously published protocols. The agr
locus was typed by a multiplex PCR protocol using specific primers de-
signed to amplify agr loci I, II, and III from S. epidermidis (32).
MLST. MLST was performed for all MRSE isolates as previously
described (33). This MLST scheme is based on the sequencing of in-
ternal fragments of seven housekeeping genes, including arcC, aroE,
gtr, mutS, pyr, tpi, and yiqL. The PCR products were purified
(QIAquick PCR purification kit; Qiagen), and both strands were se-
quenced using the BigDye fluorescent terminator with an ABI 3000
genetic analyzer (Applied Biosystems, CA). The sequences obtained
were edited using SeqMan (DNASTAR,Madison,WI) and sequence types
(STs) were assigned using the S. epidermidisMLST database (http://www
.mlst.net). Clonal complexes (CC) were determined using the eBURST
algorithm.
RESULTS
Organisms and MLST. Species-level identification for all isolates
included in the present study (n 30) was confirmed byMALDI-
TOF. Moreover, all isolates were confirmed as MRSE by amplifi-
cation of themecA gene in a singleplex PCR protocol. The major-
ity of the isolates included were recovered from corneal ulcers of
patients with clinically diagnosed bacterial keratitis (n 27), and
the others were recovered from vitreous fluids (n 3) of patients
with acute endophthalmitis following intravitreal injection,
trauma, and one case of keratitis progressing to endophthalmitis
(Table 1). Overall, 12 different STs were detected, including the
new ST493. The most common STs found in the present study
were ST59 (n 9), ST6 (n 4), ST5 (n 4), ST20 (n 3), and
ST81 (n 3). Six other STs were found (ST2, ST35, ST57, ST174,
ST179, and ST198), each corresponding to one isolate. STs were
grouped in CC by using eBURST and separation of subclusters
within the same CC was used in the present study as previously
proposed (25, 27). The vast majority of STs belonged to CC2 (28/
30; 93.3%) in the eBURST analysis, which was mainly comprised
of subcluster CC2-II (26/28; 92.9%).
SCCmec and agr typing. SCCmec type IV was the most preva-
lent (15/30; 50%) and was found mainly for isolates belonging to
CC2-II (14/26; 53.8%). The isolate grouped in the CC365 (ST174)
carried an SCCmec type IV. SCCmec type II was detected in two
isolates (ST35-CC2-I and ST20-CC2-II) and SCCmec type V in
one isolate (ST198-CC2-II), while the remaining isolates (12/30;
40%) were nontypeable. Isolates belonging to agr type I were the
most common (22/30; 73.3%), followed by agr type II (6/30;
20%), and 2 isolates were nontypeable. agr type III was not de-
tected. All ST5 isolates were agr type II, while the remaining iso-
lates clustered within CC2-II carried the agr type I locus, with the
exception of one ST59 isolate that was agr type II. A correlation
between SCCmec types and agr types was not seen, since isolates
carrying SCCmec type IV were agr type I (11/15; 73.3%%) or type
II (4/15; 26.6%).
Biofilm formation and biofilm-related genes. The ability for
biofilm formation measured by the degree of adherence to poly-
styrene microtiter plates was found for 93.3% of isolates. Most of
the isolates (50%) producedweakly adherent biofilms followed by
isolates formingmoderately (26.6%) and strongly (16.6%) adher-
ent biofilms (Table 2). Only 20 and 26.6% of isolates carried the
Molecular Epidemiology of Ocular MRSE Isolates
May 2014 Volume 52 Number 5 jcm.asm.org 1413
IS256 element and icaA gene, respectively, whereas 83.3% were
positive for aap and 40% for bhp. The aap gene was widely distrib-
uted among the STs found in the present study, being negative
only for the ST6 isolates and the single ST174 isolate. The carriage
of bhp was demonstrated to be dependent on the genetic back-
ground, since it was detected only for ST59 (8/9; 88.8%) and ST5
(4/4 100%), which were clustered within CC2-II (Table 1). The
presence of the icaA gene was also correlated with specific STs.
Isolates grouped in CC2-I were positive for icaA (2/2), while for
the isolates grouped within CC2-II, carriage of icaA was positive
only for the ST20 (3/3), ST179 (1/1) and ST198 (1/1). The isolate
belonging to the new ST493 was also icaA positive (Table 1).
Antimicrobial resistance. MIC values and susceptibility pro-
file of all MRSE and CC2-II isolates are shown in Table 3. There
was a high rate of multidrug resistance phenotype for all isolates
(76.6%) and also among isolates clusteredwithin CC2-II (80.7%).
Overall, resistance rates were particularly high for ciprofloxacin
(76.7%; MIC9016 g/ml), ofloxacin (73.3%; MIC90 16 g/ml),
moxifloxacin (33.3%, plus 30% intermediate; MIC90 2 g/ml),
azithromycin (63.3%; MIC90 32 g/ml) and gentamicin
(53.3%;MIC9032g/ml). Lower resistance rates were found for
trimethoprim-sulfamethoxazole (13.8%; MIC90 4 g/ml), tobra-
mycin (20.1%; MIC90 16 g/ml), chloramphenicol (26.7%;
MIC90 64 g/ml), and clindamycin (26.6%; MIC90 16 g/ml).
All isolates were susceptible to linezolid (MICs ranging from0.5 to
2 g/ml; MIC90 2 g/ml) and vancomycin (MICs ranging from
0.5 to 2g/ml; MIC90 2g/ml). As the majority of isolates were
grouped within CC2-II, resistance rates in this group were similar
to the overall profile, as follows: ciprofloxacin (80.7%), ofloxacin
(77%), moxifloxacin (33.3%), azithromycin (61.5%), and genta-
micin (57.7%) (data not shown).
DISCUSSION
Using an MSLT scheme to characterize the molecular epidemiol-
ogy of MRSE isolates from ocular infections, we demonstrated
that a major subcluster of CC2, subcluster CC2-II, grouped the
vast majority of isolates in our collection. Strains belonging to this
subcluster possibly represent lineages well adapted and wide-
spread in the community setting (34). The majority of isolates
examined in the present study differ from the most common
clones isolated from the hospital environment, which are also part
of CC2, but are frequently ica-positive isolates belonging to ST2
(subcluster CC2-I) (20, 35, 36). Among our isolates, only two
strains belonging to subcluster CC2-I were found. Interestingly,
only five isolates (19.2%) clustered within subcluster CC2-II (STs
20, 179, and 198) were ica positive. Conversely, a higher occur-
rence of protein-associated biofilm factors such as aap (84.6%)
and bhp (46.1%)was found among CC2-II strains, demonstrating
that their genetic background is more suitable for acquisition of
aap and bhp genes than the ica locus, except for STs 20, 179, and
198. Almost all CC2-II isolates (92.3%) were able to form biofilm
in vitro, but only 4 (15.4%) demonstrated a strong phenotype,
compatible with biofilms formed by ica-positive isolates. The
other isolates produced weak or moderate biofilms, compatible
with biofilms formed by proteinaceous factors (7). Although the
sample size in the present study was small, it seems that distinct
MRSE strains belonging to CC2-II use different mechanisms of
adaptation in the community setting, and it is tempting to infer





SCCmec and agr typing (no.
of isolates) No. of isolates positive for:
No. of MDR
isolatesb Source(s) (no. of isolates)SCCmec agr
Biofilm
formation icaA aap bhp IS256
ST59 (9) 2-II IV (7), NT (2) I (8), II (1) 8 0 9 8 1 6 Cornea (8), vitreous humor (1)
ST5 (4) 2-II IV (3), NT (1) II (4) 4 0 4 4 0 2 Cornea (4)
ST6 (4) 2-II IV (3), NT (1) I (4) 3 0 0 0 4 4 Cornea (4)
ST20 (3) 2-II II (1), NT (2) I (3) 3 3 3 0 0 2 Cornea (2), vitreous humor (1)
ST81 (3) 2-II NT (3) I (3) 3 0 3 0 0 3 Cornea (3)
ST2 (1) 2-I IV (1) I (1) 1 1 1 0 1 1 Cornea (1)
ST35 (1) 2-I II (1) I (1) 1 1 1 0 0 1 Cornea (1)
ST57 (1) 2-II IV (1) I (1) 1 0 1 0 0 1 Cornea (1)
ST174 (1) 365 IV (1) II (1) 1 0 0 0 0 1 Vitreous humor (1)
ST179 (1) 2-II NT (1) I (1) 1 1 1 0 0 1 Cornea (1)
ST198 (1) 2-II V (1) NT (1) 1 1 1 0 0 1 Cornea (1)
ST493 (1) S493 NT NT 1 1 1 0 0 1 Cornea (1)
a Abbreviations: ST, sequence type; CC, clonal complex; S, singleton; NT, nontypeable.
b Multidrug-resistant (MDR) isolates are defined as isolates resistant to at least three antimicrobial classes.
TABLE 2 Frequency of biofilm formation and -associated genes among 30 MRSE isolates according to the clonal complex
Clonal complex
(no. of isolates)
No. of isolates (%) with the following degree of biofilm
formation: No. of isolates (%) positive for:
Weak Moderate Strong
All
phenotypes icaA aap bhp IS256
CC2-II (26) 13 (50) 7 (27) 4 (15.4) 24 (92.3) 5 (19.2) 22 (84.6%) 12 (46.1) 5 (19.2)
All isolates (30) 15 (50) 8 (26.6) 5 (16.6) 28 (93.3) 8 (26.6) 25 (83.3) 12 (40) 6 (20)
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that MRSE strains lacking the ica locus are more well adapted to
the ocular surface environment than isolates carrying this locus
(since most of our isolates were recovered from keratitis cases).
Recently, it has been demonstrated that ica-negative isolates were
also predominant among S. epidermidis recovered from ocular
tissues of patients suffering with distinct ocular infections inMex-
ico (37). Carriage of the ica locus by S. epidermidis implicates a
fitness cost, and isolates lacking ica genes are able to outcompete
strains carrying this locus (38).Moreover, no association has been
demonstrated between PIA expression and colonization, whereas
Aap, in addition to its role in biofilm accumulation, has been also
demonstrated to be an important surface adhesin for skin coloni-
zation by promoting adhesion to corneocytes (39). Thus, the ab-
sence of the ica locus in the majority of CC2-II isolates compen-
sated by the carriage of the aap gene is likely to confer a selective
advantage for MRSE in community-associated ocular infections.
The spread of different S. epidermidis clones in community and
hospital environments is probably an effect of a different selective
pressure for each setting. Patients admitted to a hospital may be-
come colonizedwithmore virulent subpopulations of commensal
S. epidermidis due to different hospital selective pressure (40, 41).
Selective pressure for both strong biofilm formation ability and
antimicrobial resistance is likely to have a major impact on select-
ing S. epidermidis causing hospital-acquired device-related infec-
tions, which can explain the widespread occurrence ofmultidrug-
resistant strains carrying the ica locus and IS256 element isolated
from hospitalized patients (20, 35, 36). In addition, the site of
infection may play a role in selecting isolates with specific mech-
anisms of biofilm formation. This hypothesis is supported by a
study demonstrating that ST2 isolates from hospitalized patients
encompassed exclusively methicillin-resistant, ica- and IS256-
positive strains, which were strongly associated with bacteremia
and catheter-related infections and rarely isolated from cerebro-
spinal fluids (36). On the other hand, although biofilm formation
represents a key factor for protection against host immune re-
sponse and antimicrobial activity, the adaptive power of hospital-
associated strains seems to be restricted to this environment, since
selective pressure in the community settingmay vary according to
the group of patients and type of disease. S. epidermidis causing
ocular infections usually belongs to the patient’s periocular mi-
crobiota, which is themain source of isolates causing endophthal-
mitis (42) and possibly keratitis (1). Organisms of the periocular
microbiota can reach internal ocular tissues after trauma caused
by different conditions. For corneal infections, the most impor-
tant predisposing risk factors include contact lens wear, surgical
and nonsurgical trauma, and the presence of inflammatory ocular
surface diseases (4, 5). Organisms that are part of the ocular sur-
face microbiota can access the anterior chamber and vitreous cav-
ity following a breach due to intraocular procedures such as cata-
ract, glaucoma, and other surgeries, intravitreal injections, and
trauma caused by plant matter and other objects.
Patients presenting with corneal ulcer are immediately started
on eye drop antibiotics, usually a new 8-methoxyfluoroquin-
olone, including moxifloxacin and gatifloxacin, whereas patients
submitted to intraocular procedures are commonly subjected to a
7-day regimen (or more) of topical fluoroquinolone for prophy-
laxis of endophthalmitis (43, 44). The impact of biofilm formation
on ocular infections is well known and undoubtedly plays a major
role in the pathogenesis of such infections (45). In fact,most of the
isolates included in the present study were positive for at least one
biofilm-related gene, especially aap and bhp, both associated with
protein-related mechanism of biofilm maturation. The fact that
both the ica locus and IS256 insertion sequence are infrequent
among isolates included in the present study, as well as among
ocular isolates independently studied (37), reinforces the idea that
S. epidermidis isolates recovered from ocular tissues are not sub-
jected to a selective pressure for strong biofilm formation, since
maturation via intercellular protein adhesins results in weaker
biofilms compared to PIA-dependent mechanisms (7). However,
since the number of isolates recovered from endophthalmitis in
the present study was small, this conclusion could be true for
keratitis-associated strains only. Corroborating our results, previ-
ous reports have also found a low occurrence of the ica locus and
IS256 element among S. epidermidis comprising CC2-II (19, 36).
Taking into consideration the widespread use of fluoroquin-
olone agents for the prevention and treatment of ocular infections
asmentioned above, it ismore reasonable to associate the patterns
of antibiotic use with selection of specific MRSE strains causing
ocular infections acquired in the community setting. We found
strikingly elevated rates of nonsusceptibility among our MRSE
isolates to the fluoroquinolones ciprofloxacin, ofloxacin and
moxifloxacin and other topically used antibiotics such as azithro-
mycin and gentamicin. Previous reports have also demonstrated
markedly higher rates of resistance amongMRSA andmethicillin-
resistant CoNS (including MRSE) isolates from ocular infections
(12, 46–48). In addition, extensive use of fluoroquinolones is a
known risk factor associated with increased incidence of MRSA
carriage and infections (49, 50). Thus, fluoroquinolone selective
pressure is likely to play an important role in the selection of
successful MLST strains of MRSE causing ocular infections in a
setting with increased use of fluoroquinolones.
The genetic diversity of typeable SCCmec elements in our col-
lection was low, and there was a similar distribution of types as
found in the community setting (17, 22). Most of the MRSE iso-
lates included in the present study (15/30; 50%) carried a type IV
SCCmec, while SCCmec types II and V were identified in only 2
and 1 isolate, respectively. However, a large number of nontype-
able isolates carrying more than one ccr allotype were found, cor-
roborating previous findings that MRSE isolates from the com-
munity setting exhibit a remarkable diversity of SCCmec elements
andmay represent natural reservoirs formethicillin resistance de-
TABLE 3 Antimicrobial susceptibility profile of all 30 MRSE isolates





Range MIC50 MIC90 S I R
Ciprofloxacin 0.5 to16 16 16 23.3 - 76.7
Ofloxacin 0.25 to16 8 16 26.7 - 73.3
Moxifloxacin 0.12 to16 1 2 36.7 30.0 33.3
Azithromycin 0.5 to32 32 32 36.7 - 63.3
Tobramycin 0.25 to32 4 16 50.0 29.9 20.1
Gentamicin 0.25 to32 16 32 43.3 3.4 53.3
Clindamycin 0.12 to16 0.12 32 70.0 3.4 26.6
Chloramphenicol 2 to 64 4 64 73.3 - 26.7
Trimethoprim-sulfamethoxazole 0.25 to32 0.25 4 86.2 - 13.8
Linezolid 0.5 to 2 1 2 100 - -
Vancomycin 0.5 to 2 2 2 100 - -
a Multidrug-resistant (MDR) isolates are defined as isolates resistant to at least three
antimicrobial classes.
b Interpretive criteria as published by Clinical and Laboratory Standards Institute in
2013 (M100-S23): S, susceptible; I, intermediate; and R, resistant.
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terminants (17). In addition, as previously demonstrated, antibi-
otic exposure is associated with increased expression of ccr genes,
which could result in increased recombination between SCCmec
elements (51).
Taken together, our findings demonstrate the predominance
of a particular MRSE cluster causing ocular infections that is as-
sociated with high rates of antimicrobial resistance, particularly to
fluoroquinolone agents, and carriage of biofilm-related genes
coding for proteinaceous factors implicated in biofilm accumula-
tion. Selection by antibiotic pressure of ica-negative multidrug-
resistant MRSE strains with survival advantages to outcompete
other strains in the ocular environment may contribute to the
establishment of strains belonging to CC2-II as successful ocular
pathogens.
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